We urgently need biomarkers that are sensitive, objective, and practical. Eye-movement measures are ready to fill this gap, not as distant innovations, but as tools available today.
The post More Than Meets the Eye: Using Eye Movements in Drug Development for Neurodegenerative Diseases appeared first on MedCity News.
